Is This Penny Stock With 55% Upside A Buy Now?
This biotech company currently has an approved product on the market. However, there is more to the story than meets the eye.
Geron (GERN) Q2 2024 Earnings Call Transcript
GERN earnings call for the period ending June 30, 2024.
Is Geron Stock a Buy Following Its First New Drug Approval?
Find out if the high-flying biotech stock can keep on climbing higher.
Geron (GERN) Q1 2024 Earnings Call Transcript
GERN earnings call for the period ending March 31, 2024.
Stock Index Futures Tick Higher Ahead of U.S. Economic Data, Fed Meeting Awaited
March S&P 500 E-Mini futures (ESH24) are up +0.20%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.14% this morning as investors looked ahead to a new round of U.S. economic data and geared up for...
Geron (GERN) Q4 2023 Earnings Call Transcript
GERN earnings call for the period ending December 31, 2023.
Geron (GERN) Q3 2023 Earnings Call Transcript
GERN earnings call for the period ending September 30, 2023.